Stock MAK MATERNUS-KLINIKEN AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials Maternus-Kliniken AG

Equities

MAK

DE0006044001

Healthcare Facilities & Services

Market Closed - Xetra
Other stock markets
 11:36:01 2024-04-26 am EDT 		5-day change 1st Jan Change
1.8 EUR -4.26% Intraday chart for Maternus-Kliniken AG -3.74% -37.06%
2023 Maternus-Kliniken Aktiengesellschaft Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
2023 Maternus-Kliniken Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 48.99 39.42 42.78 91.85 101.9 35.02
Enterprise Value (EV) 1 94.2 110.5 133.7 219.1 213.1 149.6
P/E ratio -33.6 x -25 x -4.17 x -9.54 x -41 x -2.49 x
Yield - - - - - -
Capitalization / Revenue 0.39 x 0.32 x 0.34 x 0.8 x 0.91 x 0.33 x
EV / Revenue 0.74 x 0.89 x 1.07 x 1.92 x 1.91 x 1.4 x
EV / EBITDA 8.38 x 19.7 x -150 x 63.1 x 38.4 x -21.5 x
EV / FCF 19.2 x -105 x 3.81 x -11.6 x 17.6 x 33.3 x
FCF Yield 5.22% -0.95% 26.3% -8.64% 5.67% 3.01%
Price to Book -12.8 x -7.27 x -2.7 x -3.62 x -3.66 x -0.89 x
Nbr of stocks (in thousands) 20,970 20,970 20,970 20,970 20,970 20,970
Reference price 2 2.336 1.880 2.040 4.380 4.860 1.670
Announcement Date 5/1/18 4/30/19 4/30/20 4/30/21 4/29/22 6/1/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 127.1 124.3 124.4 114.3 111.4 106.7
EBITDA 1 11.24 5.622 -0.894 3.471 5.55 -6.954
EBIT 1 6.234 0.024 -4.36 0.259 2.412 -10.14
Operating Margin 4.9% 0.02% -3.5% 0.23% 2.16% -9.51%
Earnings before Tax (EBT) 1 0.859 -2.821 -10.98 -5.61 -2.166 -15.08
Net income 1 -1.456 -1.575 -10.26 -9.623 -2.485 -14.08
Net margin -1.15% -1.27% -8.24% -8.42% -2.23% -13.19%
EPS 2 -0.0694 -0.0751 -0.4891 -0.4589 -0.1185 -0.6713
Free Cash Flow 1 4.916 -1.051 35.11 -18.92 12.07 4.496
FCF margin 3.87% -0.85% 28.22% -16.55% 10.83% 4.21%
FCF Conversion (EBITDA) 43.73% - - - 217.54% -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/1/18 4/30/19 4/30/20 4/30/21 4/29/22 6/1/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 45.2 71.1 90.9 127 111 115
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 4.021 x 12.64 x -101.7 x 36.65 x 20.03 x -16.48 x
Free Cash Flow 1 4.92 -1.05 35.1 -18.9 12.1 4.5
ROE (net income / shareholders' equity) - 98.4% 124% 49.7% 13.4% 55.5%
ROA (Net income/ Total Assets) 3.55% 0.01% -1.86% 0.09% 0.88% -3.98%
Assets 1 -41.01 -12,500 552.1 -10,237 -283.6 353.9
Book Value Per Share 2 -0.1800 -0.2600 -0.7600 -1.210 -1.330 -1.870
Cash Flow per Share 2 0.3200 0.0900 0.0300 0.4700 0.6000 0.1000
Capex 1 0.98 0.92 0.7 0.71 1.91 2
Capex / Sales 0.77% 0.74% 0.56% 0.62% 1.71% 1.87%
Announcement Date 5/1/18 4/30/19 4/30/20 4/30/21 4/29/22 6/1/23
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
MATERNUS-KLINIKEN AG Stock Maternus-Kliniken AG
-37.06% 40.3M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+11.62% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. MAK Stock
  4. Financials Maternus-Kliniken AG